Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities-Reference-Cited by-同舟云学术

Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities

Author:

Venkatakrishnan K¹,Friberg LE²,Ouellet D³,Mettetal JT⁴,Stein A⁵,Trocóniz IF⁶,Bruno R⁷,Mehrotra N⁸,Gobburu J⁹,Mould DR¹⁰

Affiliation:

1. Clinical Pharmacology; Takeda Pharmaceuticals International Co.; Cambridge Massachusetts USA

2. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

3. Clinical Pharmacology; Modeling & Simulation, GlaxoSmithKline; Research Triangle Park North Carolina USA

4. Drug Safety and Metabolism, AstraZeneca R&D; Waltham Massachusetts USA

5. Novartis Institutes for Biochemical Research; Cambridge Massachusetts USA

6. Department of Pharmacy and Pharmaceutical Technology; University of Navarra; Pamplona Spain

7. Pharsight Consulting Services, Pharsight, A Certara Company; Marseille France

8. Division of Pharmacometrics, Office of Clinical Pharmacology; U.S. Food and Drug Administration; Silver Spring Maryland USA

9. Center for Translational Medicine; School of Pharmacy, University of Maryland; Baltimore Maryland USA

10. Projections Research Inc; Phoenixville Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference100 articles.

4. Model-based drug development;Lalonde;Clin. Pharmacol. Ther.,2007

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献